Piperacillin 3000 MG / tazobactam 375 MG Injection [Zosyn] — RxCUI 1659139
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Piperacillin and Tazobactam Injection: what it is, how it’s used, side effects, and interactions.
- Piperacillin and tazobactam is a powerful combination antibiotic used for serious bacterial infections that need IV treatment — things like a ruptured appendix with infection, a ba...
- What is this antibiotic actually treating — why did my doctor choose this one?
- It's given through an IV line directly into your vein, infused slowly over 30 minutes. Most patients receive it every 6 to 8 hours, and a typical course lasts 7 to 14 days dependin...
- How is this medication given, and how long will I need it?
🕸️ Concept Web — How Piperacillin 3000 MG / tazobactam 375 MG Injecti... Connects
RxCUI 1659139 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Piperacillin
8339IN -
Tazobactam
37617IN -
Piperacillin / tazobactam
74169MIN
-
Piperacillin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zosyn
74170BN
-
Zosyn
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Piperacillin / tazobactam Injection
1659130SCDF -
Piperacillin / tazobactam Injectable Product
1159278SCDG -
Piperacillin / tazobactam Injection [Zosyn]
1659133SBDF -
Zosyn Injectable Product
1186325SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Piperacillin / tazobactam Injection
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Piperacillin 3000 MG / tazobactam 375 MG Injection
1659137SCD -
Piperacillin 3000 MG
1659135SCDC -
Tazobactam 375 MG
1659136SCDC -
Piperacillin 3000 MG / tazobactam 375 MG [Zosyn]
1659138SBDC
-
Piperacillin 3000 MG / tazobactam 375 MG Injection
🔀 Generic ⇄ Brand Crosswalk
Generic (Clinical) Concepts
-
Piperacillin 3000 MG / tazobactam 375 MG Injection
SCD · 1659137 -
Piperacillin 3000 MG
SCDC · 1659135 -
Tazobactam 375 MG
SCDC · 1659136 -
Piperacillin / tazobactam Injection
SCDF · 1659130 -
Piperacillin / tazobactam Injectable Product
SCDG · 1159278
Brand-Name Concepts
-
Piperacillin 3000 MG / tazobactam 375 MG [Zosyn]
SBDC · 1659138 -
Piperacillin / tazobactam Injection [Zosyn]
SBDF · 1659133 -
Zosyn Injectable Product
SBDG · 1186325 -
Zosyn
BN · 74170
📦 FDA Products & Package NDCs
6 products · 6 package NDCs
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00206-8860-02 | 24 BAG in 1 BOX (0206-8860-02) / 50 mL in 1 BAG (0206-8860-... | Zosyn in Galaxy Containers | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 1998-03-01 |
| 00206-8861-02 | 24 BAG in 1 BOX (0206-8861-02) / 50 mL in 1 BAG (0206-8861-... | Zosyn in Galaxy Containers | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 1998-03-01 |
| 00206-8862-02 | 12 BAG in 1 BOX (0206-8862-02) / 100 mL in 1 BAG (0206-8862... | Zosyn in Galaxy Containers | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 1998-03-01 |
| 00338-9632-24 | 24 BAG in 1 CARTON (0338-9632-24) / 50 mL in 1 BAG (0338-96... | Zosyn | Baxter Healthcare Corporation | 2023-04-01 |
| 00338-9636-24 | 24 BAG in 1 CARTON (0338-9636-24) / 50 mL in 1 BAG (0338-96... | Zosyn | Baxter Healthcare Corporation | 2023-04-01 |
| 00338-9638-12 | 12 BAG in 1 CARTON (0338-9638-12) / 100 mL in 1 BAG (0338-9... | Zosyn | Baxter Healthcare Corporation | 2023-04-01 |
🧾 Billing Codes (HCPCS)
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2543 | Piperacillin/tazobactam | 3 | CMS |
🗃️ Sources & Limits
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.